NEONC TECHNOLOGIES HOLDINGS, INC. Increase Decrease In Operating Lease Liability
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Increase Decrease In Operating Lease Liability of -$33.60 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$17.84K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$15.76K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $25.06K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$16.77K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2025 was -$12.17K.
- NEONC TECHNOLOGIES HOLDINGS, INC. increase decrease in operating lease liability for fiscal 2024 was -$244.75K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$17.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$33.60K 10-Q · filed 2026-08-10 | -$8.53K derived: sum of 3 quarters · filed 2026-08-10 | -$25.30K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$15.76K 10-Q · filed 2026-05-15 | $9.30K derived: sum of 2 quarters · filed 2026-05-15 | -$7.47K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2025-12-31 | $25.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $8.29K derived: sum of 2 quarters · filed 2026-03-31 | -$12.17K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$16.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$37.23K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | -$20.46K 10-Q · filed 2026-08-10 | |||
| 2024-12-31 | -$80.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$141.44K derived: sum of 2 quarters · filed 2026-03-31 | -$244.75K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$61.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$164.37K 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | -$103.30K 10-Q · filed 2025-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |